en

PRODUCT DETAIL

VYEPTI 100 mg koncentrát na infúzny roztok

Code 9648D
MA number EU/1/21/1599/001
Product Form: con inf 1x1 ml/100 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 33 - ANTIMIGRAENICA,ANTISEROTONICA
ATC:
N NERVOUS SYSTEM
N02 ANALGESICS
N02C ANTIMIGRAINE PREPARATIONS
N02CD Calcitonin gene-related peptide (CGRP) antagonists
N02CD05 Eptinezumab
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 24.01.2022
Validity: 24.01.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 04.11.2022
eu-flag.png sk-flag.png